Exact Mass: 643.2729882

Exact Mass Matches: 643.2729882

Found 107 metabolites which its exact mass value is equals to given mass value 643.2729882, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

S-(PGA1)-glutathione

7-[(2R)-3-{[(2R)-2-{[(4S)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-2-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]sulphanyl}-2-[(1E)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid

C30H49N3O10S (643.3138494000001)


S-(PGA1)-glutathione is the gluthathione conjugate of prostaglanding A1. This conjugate is a substrate for MRP2 (31). PGA1 was observed to be able to inhibit. MRP2-mediated transport of DNP-SG quite well. S-(PGA1)-glutathione is the gluthathione conjugate of prostaglanding A1. This conjugate is a substrate for MRP2 (31). PGA1 was observed to be able to inhibit

   

S-(11-OH-9-deoxy-delta9,12-PGD2)-glutathione

(5Z)-7-[(1S,2E)-5-{[(2R)-2-{[(4R)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-2-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]sulphanyl}-3-hydroxy-2-[(3S)-3-hydroxyoctylidene]cyclopentyl]hept-5-enoic acid

C30H49N3O10S (643.3138494000001)


S-(11-OH-9-deoxy-delta9,12-PGD2)-glutathione is the glutathione conjugate of S-(11-OH-9-deoxy-delta9,12-PGD2) [HMDB] S-(11-OH-9-deoxy-delta9,12-PGD2)-glutathione is the glutathione conjugate of S-(11-OH-9-deoxy-delta9,12-PGD2).

   

S-(9-deoxy-delta12-PGD2)-glutathione

(5Z)-7-[(1R,2R)-2-[(3S)-1-{[(2S)-2-{[(4R)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-2-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]sulphanyl}-3-hydroxyoctyl]-3-oxocyclopentyl]hept-5-enoic acid

C30H49N3O10S (643.3138494000001)


S-(9-hydroxy-PGA1)-glutathione is the glutathione conjugate of S-(9-deoxy-delta12-PGD2) [HMDB] S-(9-hydroxy-PGA1)-glutathione is the glutathione conjugate of S-(9-deoxy-delta12-PGD2).

   

S-(9-hydroxy-PGA2)-glutathione

(5Z)-7-[(1R,2S)-3-{[(2S)-2-{[(4R)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-2-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]sulphanyl}-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid

C30H49N3O10S (643.3138494000001)


S-(9-hydroxy-PGA2)-glutathione is the glutathione conjugate of S-(9-hydroxy-PGA2). Inside L1210 cells, PGA2 was initially conjugated to glutathione and then reduced at the 9-keto position to form 9-OH-PGA2-GSH. The 9-OH-PGA2-GSH was then secreted from the cells and apparently degraded to form the CysGly and Cys derivatives. Intracellular glutathione was decreased markedly by the addition of the PGA2 in L1210 and L929 cells. This result confirms that conjugation of PGA2 to glutathione occurs in both cell types. Formation of the 9-OH-PGA2-GSH and other glutathione-related conjugates was prevented when glutathione was depleted by growth in buthionine sulfoximine. The glutathione-depleted cells were insensitive to the cytotoxicity of the PGA2, suggesting that one of the glutathione-related conjugates may be involved in the cytotoxicity of PGA2. These results end the controversy over the metabolism of PGA2 and suggest mechanisms for its antiviral and antigrowth actions. S-(9-hydroxy-PGA2)-glutathione is the glutathione conjugate of S-(9-hydroxy-PGA2)

   

10,11-Dihydro-12R-hydroxy-leukotriene C4

(5S,6R,7E,9E,12S,14Z)-6-{[(2R)-2-{[(4R)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-2-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]sulfanyl}-5,12-dihydroxyicosa-7,9,14-trienoic acid

C30H49N3O10S (643.3138494000001)


This compound belongs to the family of Leukotrienes. These are eicosanoids containing an hydroxyl group attached to the aliphati chain of an arachidonic acid.

   

11S,15S-dihydroxy-14R-(S-glutathionyl)-5Z,8Z,12E-eicosatrienoic acid

(8Z,11S,12E,14R,15S)-14-{[(2R)-2-{[(4S)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-2-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]sulphanyl}-11,15-dihydroxyicosa-5,8,12-trienoic acid

C30H49N3O10S (643.3138494000001)


11S,15S-dihydroxy-14R-(S-glutathionyl)-5Z,8Z,12E-eicosatrienoic acid is classified as a member of the Oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. 11S,15S-dihydroxy-14R-(S-glutathionyl)-5Z,8Z,12E-eicosatrienoic acid is considered to be practically insoluble (in water) and acidic. 11S,15S-dihydroxy-14R-(S-glutathionyl)-5Z,8Z,12E-eicosatrienoic acid is an eicosanoid lipid molecule

   

Methoxymorpholinyldoxorubicin

6,8,11-trihydroxy-10-{[5-hydroxy-4-(2-methoxymorpholin-4-yl)-6-methyloxan-2-yl]oxy}-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

C32H37NO13 (643.2264792000001)


   

Sabarubicin

7-({5-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-4-hydroxy-6-methyloxan-2-yl}oxy)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

C32H37NO13 (643.2264792000001)


   

Satavaptan

1-(4-(N-Tert-butylcarbamoyl)-2-methoxybenzenesulfonyl)-5-ethoxy-3-spiro(4-(2-morpholinoethoxy)cyclohexane)indoline-2-one, phosphate monohydrate cis-isomer

C33H45N3O8S (643.292721)


C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents

   

Ulongamide B

Ulongamide B

C32H45N5O7S (643.303954)


   

2,6,14-Triacetoxy-1-(3-furylcarbonyloxy)-9-(nicotinoyloxy)dihydro-alpha-agarofuran-4-ol

2,6,14-Triacetoxy-1-(3-furylcarbonyloxy)-9-(nicotinoyloxy)dihydro-alpha-agarofuran-4-ol

C32H37NO13 (643.2264792000001)


   

2,6,14-Triacetoxy-9-(3-furylcarbonyloxy)-1-(nicotinoyloxy)dihydro-alpha-agarofuran-4-ol

2,6,14-Triacetoxy-9-(3-furylcarbonyloxy)-1-(nicotinoyloxy)dihydro-alpha-agarofuran-4-ol

C32H37NO13 (643.2264792000001)


   

1beta,7beta,11-triacetoxy-4alpha-hydroxy-5alpha-nicotinoyl-8beta-furanoyldihydroagarofuran|triptersinine F

1beta,7beta,11-triacetoxy-4alpha-hydroxy-5alpha-nicotinoyl-8beta-furanoyldihydroagarofuran|triptersinine F

C32H37NO13 (643.2264792000001)


   

(?)-(A-c)-8beta-acetoxy-14alpha-benzoyloxy-N-ethyl-13beta,15alpha-dihydroxy-1alpha,6alpha,16beta,18-tetramethoxy-19-oxo-aconitane

(?)-(A-c)-8beta-acetoxy-14alpha-benzoyloxy-N-ethyl-13beta,15alpha-dihydroxy-1alpha,6alpha,16beta,18-tetramethoxy-19-oxo-aconitane

C34H45NO11 (643.299246)


   

1beta,5alpha,11-triacetoxy-4alpha-hydroxy-7beta-nicotinoyl-8beta-furanoyldihydroagarofuran|triptersinine G

1beta,5alpha,11-triacetoxy-4alpha-hydroxy-7beta-nicotinoyl-8beta-furanoyldihydroagarofuran|triptersinine G

C32H37NO13 (643.2264792000001)


   

Arg Phe Asn Ala His

Arg Phe Asn Ala His

C28H41N11O7 (643.3190276)


   

Glu Phe Trp Tyr

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Glu Phe Tyr Trp

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Glu Trp Phe Tyr

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Glu Trp Tyr Phe

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Glu Tyr Phe Trp

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Glu Tyr Trp Phe

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Phe Glu Trp Tyr

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Phe Glu Tyr Trp

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Phe Trp Glu Tyr

(4S)-4-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Phe Trp Tyr Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]pentanedioic acid

C34H37N5O8 (643.2642002)


   

Phe Tyr Glu Trp

(4S)-4-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Phe Tyr Trp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

C34H37N5O8 (643.2642002)


   

Ile Trp Tyr Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C35H41N5O7 (643.3005836)


   

Ile Tyr Trp Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C35H41N5O7 (643.3005836)


   

Ile Tyr Tyr Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C35H41N5O7 (643.3005836)


   

Leu Trp Tyr Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C35H41N5O7 (643.3005836)


   

Leu Tyr Trp Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C35H41N5O7 (643.3005836)


   

Leu Tyr Tyr Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C35H41N5O7 (643.3005836)


   

Trp Glu Phe Tyr

(4S)-4-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Trp Glu Tyr Phe

(4S)-4-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Trp Phe Glu Tyr

(4S)-4-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-4-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Trp Phe Tyr Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]pentanedioic acid

C34H37N5O8 (643.2642002)


   

Trp Ile Tyr Tyr

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C35H41N5O7 (643.3005836)


   

Trp Leu Tyr Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C35H41N5O7 (643.3005836)


   

Trp Tyr Glu Phe

(4S)-4-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Trp Tyr Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]pentanedioic acid

C34H37N5O8 (643.2642002)


   

Trp Tyr Ile Tyr

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C35H41N5O7 (643.3005836)


   

Trp Tyr Leu Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C35H41N5O7 (643.3005836)


   

Trp Tyr Tyr Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanoic acid

C35H41N5O7 (643.3005836)


   

Trp Tyr Tyr Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanoic acid

C35H41N5O7 (643.3005836)


   

Tyr Glu Phe Trp

(4S)-4-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Tyr Glu Trp Phe

(4S)-4-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Tyr Phe Glu Trp

(4S)-4-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Tyr Phe Trp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

C34H37N5O8 (643.2642002)


   

Tyr Ile Trp Tyr

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C35H41N5O7 (643.3005836)


   

Tyr Ile Tyr Trp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C35H41N5O7 (643.3005836)


   

Tyr Leu Trp Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C35H41N5O7 (643.3005836)


   

Tyr Leu Tyr Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C35H41N5O7 (643.3005836)


   

Tyr Trp Glu Phe

(4S)-4-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C34H37N5O8 (643.2642002)


   

Tyr Trp Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]pentanedioic acid

C34H37N5O8 (643.2642002)


   

Tyr Trp Ile Tyr

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C35H41N5O7 (643.3005836)


   

Tyr Trp Leu Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C35H41N5O7 (643.3005836)


   

Tyr Trp Tyr Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanoic acid

C35H41N5O7 (643.3005836)


   

Tyr Trp Tyr Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanoic acid

C35H41N5O7 (643.3005836)


   

Tyr Tyr Ile Trp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C35H41N5O7 (643.3005836)


   

Tyr Tyr Leu Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C35H41N5O7 (643.3005836)


   

Tyr Tyr Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C35H41N5O7 (643.3005836)


   

Tyr Tyr Trp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C35H41N5O7 (643.3005836)


   

RFNAH

Arg Phe Asn Ala His

C28H41N11O7 (643.3190276)


   

14,15-HxA3-C(11S)

11S,15S-dihydroxy-14R-(S-glutathionyl)-5Z,8Z,12E-eicosatrienoic acid

C30H49N3O10S (643.3138494000001)


   

Nemorubicin

Nemorubicin

C32H37NO13 (643.2264792000001)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

5-[3-[[3-(Fluorosulfonyl)phenyl]amino]-1,3-dioxopropyl]-2-(hexadecyloxy)benzenesulfonyl fluoride

5-[3-[[3-(Fluorosulfonyl)phenyl]amino]-1,3-dioxopropyl]-2-(hexadecyloxy)benzenesulfonyl fluoride

C31H43F2NO7S2 (643.2448872000001)


   

Euphorbia factor L9

Euphorbia factor L9

C37H41NO9 (643.2781176000001)


   

Benzoylmesaconine hydrochloride

Benzoylmesaconine hydrochloride

C31H46ClNO11 (643.2759236)


   

Sabarubicin

Sabarubicin

C32H37NO13 (643.2264792000001)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

Bdy 650-X, SE

Bdy 650-X, SE

C33H32BF2N5O6 (643.2413586)


   

Gsh-prostaglandin A1

Gsh-prostaglandin A1

C30H49N3O10S (643.3138494000001)


   

1-[1-Carboxylato-3-[[3-carboxylato-5-[3-[decanoyl(hydroxy)amino]propylamino]-3-hydroxy-5-oxopentanoyl]amino]propyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylate

1-[1-Carboxylato-3-[[3-carboxylato-5-[3-[decanoyl(hydroxy)amino]propylamino]-3-hydroxy-5-oxopentanoyl]amino]propyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylate

C28H43N4O13-3 (643.2826488000001)


   

11S,15S-Dihydroxy-14R-(S-glutathionyl)-5Z,8Z,12E-eicosatrienoate

11S,15S-Dihydroxy-14R-(S-glutathionyl)-5Z,8Z,12E-eicosatrienoate

C30H49N3O10S (643.3138494000001)


   

10,11-Dihydro-12R-hydroxy-leukotriene C4

10,11-Dihydro-12R-hydroxy-leukotriene C4

C30H49N3O10S (643.3138494000001)


   

N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-thiophenesulfonamide

N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-thiophenesulfonamide

C33H45N3O6S2 (643.2749630000001)


   

N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide

N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide

C31H44F3N3O6S (643.290276)


   

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methoxybenzenesulfonamide

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methoxybenzenesulfonamide

C36H41N3O6S (643.2715926000001)


   

N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide

N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide

C31H44F3N3O6S (643.290276)


   

(2R,3R,4S,5R)-2-acetamido-4-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5,6-trihydroxyhexanoic acid

(2R,3R,4S,5R)-2-acetamido-4-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5,6-trihydroxyhexanoic acid

C24H41N3O17 (643.2435856000001)


   

S-(PGA1)-glutathione

S-(PGA1)-glutathione

C30H49N3O10S (643.3138494000001)


   

Satavaptan

Satavaptan

C33H45N3O8S (643.292721)


C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents

   

S-(11-OH-9-deoxy-delta9,12-PGD2)-glutathione

S-(11-OH-9-deoxy-delta9,12-PGD2)-glutathione

C30H49N3O10S (643.3138494000001)


   

11(S),15(S)-dihydroxy-14(R)-(S-glutathionyl)-5(Z),8(Z),12(E)-icosatrienoic acid

11(S),15(S)-dihydroxy-14(R)-(S-glutathionyl)-5(Z),8(Z),12(E)-icosatrienoic acid

C30H49N3O10S (643.3138494000001)


A glutathione conjugate in which the thiol hydrogen of glutathione has been replaced by a (6S,7R,8E,10S,12Z,15Z)-19-carboxy-6,10-dihydroxynonadeca-8,12,15-trien-7-yl group.

   

PE 18:3/8:3;O3

PE 18:3/8:3;O3

C31H50NO11P (643.312132)


   

PE 18:4/8:2;O3

PE 18:4/8:2;O3

C31H50NO11P (643.312132)


   

PE 26:6;O3

PE 26:6;O3

C31H50NO11P (643.312132)


   

LNAPS 25:5;O

LNAPS 25:5;O

C31H50NO11P (643.312132)


   

PS O-25:6;O2

PS O-25:6;O2

C31H50NO11P (643.312132)


   

PS P-16:1/9:4;O2

PS P-16:1/9:4;O2

C31H50NO11P (643.312132)


   

PS P-18:1/7:4;O2

PS P-18:1/7:4;O2

C31H50NO11P (643.312132)


   

PS 18:2/7:3;O

PS 18:2/7:3;O

C31H50NO11P (643.312132)


   

PS 20:4/5:1;O

PS 20:4/5:1;O

C31H50NO11P (643.312132)


   

PS 20:5/4:1;O2

PS 20:5/4:1;O2

C30H46NO12P (643.2757486)


   

PS 24:6;O2

PS 24:6;O2

C30H46NO12P (643.2757486)


   

PS 25:5;O

PS 25:5;O

C31H50NO11P (643.312132)


   

ST 23:2;O8;HexNAc

ST 23:2;O8;HexNAc

C31H49NO13 (643.3203744)


   

ST 26:7;O6;HexNAc

ST 26:7;O6;HexNAc

C34H45NO11 (643.299246)


   

BIBO3304 (TFA)

BIBO3304 (TFA)

C31H36F3N7O5 (643.2729882)


BIBO3304 TFA is a potent, orally active, and selective neuropeptide Y (NPY) Y1 receptor antagonist, with subnanomolar affinity for both the human and the rat Y1 receptor (IC50=0.38 and 0.72 nM, respectively)[1].

   

1α-nicotinoyloxy-2α-acetoxy-6β-acetoxy-9β-furoyloxy-11-acetoxy-4β-hydroxydihydro-β-agarofuran

NA

C32H37NO13 (643.2264792000001)


{"Ingredient_id": "HBIN002314","Ingredient_name": "1\u03b1-nicotinoyloxy-2\u03b1-acetoxy-6\u03b2-acetoxy-9\u03b2-furoyloxy-11-acetoxy-4\u03b2-hydroxydihydro-\u03b2-agarofuran","Alias": "NA","Ingredient_formula": "C32H37NO13","Ingredient_Smile": "CC(=O)OCC12C(CC3C(C1(C(CC(C2OC(=O)C4=CN=CC=C4)OC(=O)C)(C)O)OC3(C)C)OC(=O)C)OC(=O)C5=COC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15526","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2s,5s,8s,11s,14r,15r)-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

(2s,5s,8s,11s,14r,15r)-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C32H45N5O7S (643.303954)


   

(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C32H37NO13 (643.2264792000001)


   

(2s,5s,11s,14r,15r)-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

(2s,5s,11s,14r,15r)-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C32H45N5O7S (643.303954)


   

(1r,2s,4s,5s,6s,7s,9s,12s)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

(1r,2s,4s,5s,6s,7s,9s,12s)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C32H37NO13 (643.2264792000001)


   

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(furan-3-carbonyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate

C32H37NO13 (643.2264792000001)


   

4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-5-isopropyl-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C32H45N5O7S (643.303954)